Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd. is a registered legal entity registered in China, and its current status with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is active. Its registered address on file is Beijing, China. 5 shareholders are on record for Pharmaron Beijing Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Pharmaron Beijing Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC.
The largest of these is BNY Mellon Global Emerging Markets Fund, holding 5.3% — the largest recorded stake — followed by Fidelity China Region Fund at 3.8%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 10 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| BNY Mellon Global Emerging Markets Fund | 5.3% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| Fidelity China Region Fund | 3.8% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| DFA Emerging Markets Core Equity Portfolio | 3.4% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| JP Morgan Trust IV-JP Morgan Emg Mkts Research Enhanced Equity Fd | 2.9% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| Fidelity Series Global Ex U.S. Index Fund | 2.5% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) |
Officers
5
The Executive Vp & Executive Director of Pharmaron Beijing Co., Ltd. on record is Bei Zheng M.a, M.a.; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System).
The register reports 11 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Pharmaron Beijing Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Pharmaron Beijing Co., Ltd.?
Five shareholders are currently on record for Pharmaron Beijing Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is BNY Mellon Global Emerging Markets Fund, holding 5.3% — the largest recorded stake — followed by Fidelity China Region Fund at 3.8%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Pharmaron Beijing Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Pharmaron Beijing Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Pharmaron Beijing Co., Ltd. have on record?
5 shareholders are shown on record for Pharmaron Beijing Co., Ltd.. The register reports 10 in total; only the top 5 by holding are shown here.
Is Pharmaron Beijing Co., Ltd. still an active company?
Pharmaron Beijing Co., Ltd.'s status on SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is listed as active.
What is Pharmaron Beijing Co., Ltd.'s registered address?
The registered address on file for Pharmaron Beijing Co., Ltd. is Beijing, China.
Who are the officers/directors of Pharmaron Beijing Co., Ltd.?
The Executive Vp & Executive Director of Pharmaron Beijing Co., Ltd. on record is Bei Zheng M.a, M.a.; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Pharmaron Beijing Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Pharmaron Beijing Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Zavia's monitoring API can track changes to Pharmaron Beijing Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Pharmaron Beijing Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including China, so records like Pharmaron Beijing Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last synced on 22 September 2026.